BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jain S, Sharma P, Dhull VS, Bal C, Kumar R. Lymphoma as a second malignancy in a patient with neuroendocrine tumor: mimicking dedifferentiation on dual-tracer PET/CT with 68Ga-DOTANOC and 18F-FDG. Clin Nucl Med 2014;39:358-9. [PMID: 24217543 DOI: 10.1097/RLU.0b013e31828e98c5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Juntikka T, Vaittinen S, Vahlberg T, Jyrkkiö S, Minn H. Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes. Front Oncol 2021;11:710900. [PMID: 34307181 DOI: 10.3389/fonc.2021.710900] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ruuska T, Ramírez Escalante Y, Vaittinen S, Gardberg M, Kiviniemi A, Marjamäki P, Kemppainen J, Jyrkkiö S, Minn H. Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at 68Ga-DOTANOC PET/CT imaging. Acta Oncol 2018;57:283-9. [PMID: 28686510 DOI: 10.1080/0284186X.2017.1342864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
3 Karunanithi S, Roy SG, Sharma P, Yadav R, Bal C, Kumar R. Metastatic Neuroendocrine Tumour in a Renal Transplant Recipient: Dual-Tracer PET-CT with (18)F-FDG and (68)Ga-DOTANOC in This Rare Setting. Nucl Med Mol Imaging 2015;49:57-60. [PMID: 25767623 DOI: 10.1007/s13139-014-0297-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]